Table 1
Open in new tab

Baseline patient characteristics

CharacteristicPhase I (n = 17)Phase IIa (n = 11)
Median age (range), yr55 (30–67)52 (33–70)
Sex
Male10 (58.8)5 (45.5)
Female7 (41.2)6 (54.5)
ECOG performance status
02 (11.8)1 (9.1)
115 (88.2)10 (90.9)
20 (0)0 (0)
Site of primary tumor
Stomach13 (76.5)11 (100)
Colon or rectum2 (11.8)0 (0)
Parotid gland1 (5.9)0 (0)
Salivary gland1 (5.9)0 (0)
Disease location
Cardia1 (7.7)1 (9.1)
Body3 (23.1)4 (36.4)
Antrum8 (61.5)5 (45.5)
Diffuse1 (7.7)1 (9.1)
Extent of disease
Metastatic13 (100)7 (63.6)
Recurrent0 (0)4 (36.4)
Locally advanced0 (0)0 (0)
Metastatic sites
Lung3 (17.6)0 (0)
Lymph node14 (82.4)5 (45.5)
Liver9 (52.9)3 (27.3)
Bone2 (11.8)0 (0)
Others4 (23.5)7 (63.6)
Previous surgery5 (29.4)7 (63.6)
CharacteristicPhase I (n = 17)Phase IIa (n = 11)
Median age (range), yr55 (30–67)52 (33–70)
Sex
Male10 (58.8)5 (45.5)
Female7 (41.2)6 (54.5)
ECOG performance status
02 (11.8)1 (9.1)
115 (88.2)10 (90.9)
20 (0)0 (0)
Site of primary tumor
Stomach13 (76.5)11 (100)
Colon or rectum2 (11.8)0 (0)
Parotid gland1 (5.9)0 (0)
Salivary gland1 (5.9)0 (0)
Disease location
Cardia1 (7.7)1 (9.1)
Body3 (23.1)4 (36.4)
Antrum8 (61.5)5 (45.5)
Diffuse1 (7.7)1 (9.1)
Extent of disease
Metastatic13 (100)7 (63.6)
Recurrent0 (0)4 (36.4)
Locally advanced0 (0)0 (0)
Metastatic sites
Lung3 (17.6)0 (0)
Lymph node14 (82.4)5 (45.5)
Liver9 (52.9)3 (27.3)
Bone2 (11.8)0 (0)
Others4 (23.5)7 (63.6)
Previous surgery5 (29.4)7 (63.6)

Unless otherwise noted, values are number (percentage) of patients.

In total, 24 patients had gastric cancer (phase I, n = 13; phase IIa, n = 11), which was classified by disease location and extent.

Abbreviation: ECOG, Eastern Cooperative Oncology Group.

Table 1
Open in new tab

Baseline patient characteristics

CharacteristicPhase I (n = 17)Phase IIa (n = 11)
Median age (range), yr55 (30–67)52 (33–70)
Sex
Male10 (58.8)5 (45.5)
Female7 (41.2)6 (54.5)
ECOG performance status
02 (11.8)1 (9.1)
115 (88.2)10 (90.9)
20 (0)0 (0)
Site of primary tumor
Stomach13 (76.5)11 (100)
Colon or rectum2 (11.8)0 (0)
Parotid gland1 (5.9)0 (0)
Salivary gland1 (5.9)0 (0)
Disease location
Cardia1 (7.7)1 (9.1)
Body3 (23.1)4 (36.4)
Antrum8 (61.5)5 (45.5)
Diffuse1 (7.7)1 (9.1)
Extent of disease
Metastatic13 (100)7 (63.6)
Recurrent0 (0)4 (36.4)
Locally advanced0 (0)0 (0)
Metastatic sites
Lung3 (17.6)0 (0)
Lymph node14 (82.4)5 (45.5)
Liver9 (52.9)3 (27.3)
Bone2 (11.8)0 (0)
Others4 (23.5)7 (63.6)
Previous surgery5 (29.4)7 (63.6)
CharacteristicPhase I (n = 17)Phase IIa (n = 11)
Median age (range), yr55 (30–67)52 (33–70)
Sex
Male10 (58.8)5 (45.5)
Female7 (41.2)6 (54.5)
ECOG performance status
02 (11.8)1 (9.1)
115 (88.2)10 (90.9)
20 (0)0 (0)
Site of primary tumor
Stomach13 (76.5)11 (100)
Colon or rectum2 (11.8)0 (0)
Parotid gland1 (5.9)0 (0)
Salivary gland1 (5.9)0 (0)
Disease location
Cardia1 (7.7)1 (9.1)
Body3 (23.1)4 (36.4)
Antrum8 (61.5)5 (45.5)
Diffuse1 (7.7)1 (9.1)
Extent of disease
Metastatic13 (100)7 (63.6)
Recurrent0 (0)4 (36.4)
Locally advanced0 (0)0 (0)
Metastatic sites
Lung3 (17.6)0 (0)
Lymph node14 (82.4)5 (45.5)
Liver9 (52.9)3 (27.3)
Bone2 (11.8)0 (0)
Others4 (23.5)7 (63.6)
Previous surgery5 (29.4)7 (63.6)

Unless otherwise noted, values are number (percentage) of patients.

In total, 24 patients had gastric cancer (phase I, n = 13; phase IIa, n = 11), which was classified by disease location and extent.

Abbreviation: ECOG, Eastern Cooperative Oncology Group.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close